Titan Medical Inc., a development stage company, focuses on design and development of robotic surgical system for application in minimally invasive surgery (MIS). The company is developing SPORT Surgical System, a single-port robotic surgical system that comprises a surgeon-controlled patient cart, which includes a 3D vision system and multi-articulating instruments for performing MIS procedures; and a surgeon workstation that provides the surgeon with ergonomic interface to the patient cart and a 3D endoscopic view inside the patient's body during MIS procedures. The SPORT Surgical System enables surgeons to perform various surgical procedures for general abdominal, gynecologic, urologic, and colorectal indications. The company is headquartered in Toronto, Canada.
Industry, Sector and Symbol
Stock Exchange NASDAQ
Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:TMDI
Previous Symbol
CUSIPN/A
Phone416-548-8522
Debt
Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A
Profitability
EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A
Miscellaneous
Employees9
Outstanding Shares14,000,000
Market Cap$26.73 million
OptionableNot Optionable
Titan Medical (NASDAQ:TMDI) Frequently Asked Questions
What is Titan Medical's stock symbol?
Titan Medical trades on the NASDAQ under the ticker symbol "TMDI."
When is Titan Medical's next earnings date?
What price target have analysts set for TMDI?
3 brokerages have issued 12 month price objectives for Titan Medical's shares. Their forecasts range from $6.00 to $8.00. On average, they expect Titan Medical's share price to reach $6.6667 in the next twelve months. This suggests a possible upside of 243.6% from the stock's current price. View Analyst Price Targets for Titan Medical.
What is the consensus analysts' recommendation for Titan Medical?
3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Titan Medical in the last year. There are currently 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Titan Medical.
Has Titan Medical been receiving favorable news coverage?
Media stories about TMDI stock have trended somewhat positive recently, according to InfoTrie Sentiment. The research group scores the sentiment of media coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Titan Medical earned a media sentiment score of 1.8 on InfoTrie's scale. They also assigned news stories about the company a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an effect on the stock's share price in the near term.
Who are some of Titan Medical's key competitors?
Some companies that are related to Titan Medical include Endologix (ELGX), RA Medical Systems (RMED), Sensus Healthcare (SRTS), Invo Bioscience (IVOB), STRATA Skin Sciences (SSKN), Apollo Endosurgery (APEN), Restoration Robotics (HAIR), Arch Therapeutics (ARTH), Repro-Med Systems (REPR), Pro-Dex (PDEX), CAS Medical Systems (CASM), Motus GI (MOTS), iCAD (ICAD), Obalon Therapeutics (OBLN) and Spectral Medical (EDTXF).
Who are Titan Medical's key executives?
Titan Medical's management team includes the folowing people:
- Mr. David J. McNally, Pres, CEO & Director (Age 56)
- Mr. Stephen D. Randall, CFO, Sec. & Director
- Dr. Perry A. Genova, Sr. VP of R&D
- Mr. Christopher Seibert, VP of Bus. Devel.
- Mr. Curtis R. Jensen, VP of Quality & Regulatory Affairs
Who are Titan Medical's major shareholders?
Titan Medical's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Sio Capital Management LLC (3.18%) and Highbridge Capital Management LLC (1.71%).
Which institutional investors are buying Titan Medical stock?
TMDI stock was bought by a variety of institutional investors in the last quarter, including Sio Capital Management LLC and Highbridge Capital Management LLC.
How do I buy shares of Titan Medical?
Shares of TMDI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Titan Medical's stock price today?
One share of TMDI stock can currently be purchased for approximately $1.94.
How big of a company is Titan Medical?
Titan Medical has a market capitalization of $26.73 million. Titan Medical employs 9 workers across the globe.
What is Titan Medical's official website?
How can I contact Titan Medical?
Titan Medical's mailing address is 170 UNIVERSITY AVENUE, TORONTO A6, M5H 3B3. The company can be reached via phone at 416-548-8522.
MarketBeat Community Rating for Titan Medical (NASDAQ TMDI)
MarketBeat's community ratings are surveys of what our community members think about Titan Medical and other stocks. Vote "Outperform" if you believe TMDI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe TMDI will underperform the S&P 500 over the long term. You may vote once every thirty days.
